Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFINA: Flexible Dose Fesoterodine in OAB
NCT00806494Phase 4Completed
- Sponsor
- Pfizer
- Start
- Feb 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fesoterodine in overactive bladder (OAB), sponsored by Pfizer. Started Feb 2009; status: completed.
02
Drugs
fesoterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00806494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00806494.